Minitran 0.4 mg/HR 24HR Transdermal System
RxNorm 861663
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 861663 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Minitran 0.4 mg/HR 24HR Transdermal System.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SY
Synonym (SY):
24 HR Minitran 0.4 mg/HR Transdermal System
(Atom ID: 8247599)
SBD
Semantic Branded Drug (SBD):
24 HR nitroglycerin 0.4 mg/HR Transdermal System [Minitran]
(Atom ID: 12366885)
SY
Synonym (SY):
24 HR NTG 0.4 mg/HR Transdermal System [Minitran]
(Atom ID: 8248918)
SY
Synonym (SY):
24 HR TNG 0.4 mg/HR Transdermal System [Minitran]
(Atom ID: 8248911)
SY
Synonym (SY):
Minitran 0.4 mg/HR 24 HR Transdermal Patch
(Atom ID: 3035411)
PSN
Prescribable Name (PSN):
Minitran 0.4 mg/HR 24HR Transdermal System
(Atom ID: 7265088)
SY
Synonym (SY):
Minitran 0.4 mg/HR 24HR Transdermal System
(Atom ID: 8246384)
Patient Education
Nitroglycerin Transdermal Patch
Nitroglycerin transdermal patches are used to prevent episodes of angina (chest pain) in people who have coronary artery disease (narrowing of the blood vessels that supply blood to the heart). Nitroglycerin transdermal patches can only be used to prevent attacks of angina; they cannot be used to treat an attack of angina once it has begun. Nitroglycerin is in a class of medications called vasodilators. It works by relaxing the blood vessels so that the heart does not need to work as hard and therefore does not need as much oxygen.
[Learn More]
* Please review the disclaimer below.